---
title: "Dynavax Technologies Corp. (DVAX) rose 39%, marking its best intraday performance in the last four y"
description: "Dynavax Technologies Corp. (DVAX) rose 39%, marking its best intraday performance in the last four years, following the company's agreement with Sanofi"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/270734998.md"
published_at: "2025-12-24T14:34:19.000Z"
---

# Dynavax Technologies Corp. (DVAX) rose 39%, marking its best intraday performance in the last four y

> Dynavax Technologies Corp. (DVAX) rose 39%, marking its best intraday performance in the last four years, following the company's agreement with Sanofi

Dynavax Technologies Corp. (DVAX) rose 39%, marking its best intraday performance in the last four years, following an agreement with Sanofi

### Related Stocks

- [SNYNF.US - Sanofi](https://longbridge.com/en/quote/SNYNF.US.md)
- [SNY.US - Sanofi](https://longbridge.com/en/quote/SNY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 4-Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant | Sanofi has ousted CEO Paul Hudson after a six-year tenure marked by a stalled turnaround and pressure on vaccine sales.  | [Link](https://longbridge.com/en/news/275748711.md) |
| Sanofi Kicks Off Up to EUR1 Billion Share Buyback | Sanofi Kicks Off Up to EUR1 Billion Share Buyback | [Link](https://longbridge.com/en/news/274608524.md) |
| Sanofi Wins US FDA, Japanese Designations for Warm Autoimmune Hemolytic Drug | Sanofi Wins US FDA, Japanese Designations for Warm Autoimmune Hemolytic Drug | [Link](https://longbridge.com/en/news/275274188.md) |
| Belén Garijo Named CEO of Sanofi | Sanofi SA has appointed Belén Garijo as the new CEO, effective after the Annual General Meeting on April 29, 2026. Curre | [Link](https://longbridge.com/en/news/275708715.md) |
| Sanofi Completes Acquisition of Dynavax Technologies | Sanofi has completed its acquisition of Dynavax Technologies, adding the adult hepatitis B vaccine HEPLISAV-B and other  | [Link](https://longbridge.com/en/news/275471636.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.